Approved Study Database

Ref. No. Scientific Title Principal investigator
2020.532 A PHASE II/III, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF TIRAGOLUMAB IN COMBINATION WITH ATEZOLIZUMAB PLUS PEMETREXED AND CARBOPLATIN/CISPLATIN VERSUS PEMBROLIZUMAB PLUS PEMETREXED AND CARBOPLATIN/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER Prof. MOK Tony Shu Kam
莫樹錦教授
2018.465 Brigatinib in Patients With Anaplastic Lymphoma Kinase- Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib Prof. MOK Tony Shu Kam
莫樹錦
2019.584 A randomized, open-label, multicenter phase II study evaluating the efficacy and safety of capmatinib (INC280) plus pembrolizumab versus pembrolizumab alone as first line treatment for locally advanced or metastatic non-small cell lung cancer with PD-L1≥ 50% Prof. MOK Tony Shu Kam
莫樹錦教授
2013.461 A multicenter, open-label, randomized phase II study to evaluate the efficacy of AUY922 vs pemetrexed or docetaxel in NSCLC patients with EGFR mutations who have progressed on prior EGFR TKI treatment Prof. MOK Tony Shu Kam
2007.246 A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer Prof. MOK Tony SK
2008.249 Randomized, Open Label, Phase III Trial of CP-751, 871 in Combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin in Patients with Non-Small Cell Lung Cancer Prof MOK Tony, S.K.
2013.660 Evaluation of the need of CM services for stroke patients in Hong Kong Prof. MOK Vincent
2014.276 Danshen and Gegen in improving Cerebral Haemodynamics in Cerebral White Matter Hyperintensities: A Pilot Study Prof. MOK Vincent
2008.023 Mechanisms for Cognitive Impairment in Chinese Patients with Confluent White Matter Lesion: Analysis of 99 Structural Brain Regions Using a Hybrid Volumetric and Surface Warping Prof Mok Vincent
2020.536 Enhancing Use of Telemedicine among Older People amid COVID-19 In Asia (EUTOPIA ) Prof. MOK Vincent
2019.371 Biomarkers in Neurodegenerative Diseases (NDD Registry) Prof. MOK Vincent
莫仲棠
2023.348 Brain Heath Service for Prevention of AD Prof. MOK Vincent
莫仲棠
2014.213 Physiological basis of motor facilitation by visual cues in Parkinson's disease Prof Mok Vincent
2013.681 A nested case-control study to investigate microRNA as a screening biomarker for asymptomatic elders with white matter hyperintensities at risk of incident dementia and stroke Prof. Mok Vincent C T
2012.167 MicroRNA expression pattern in stroke patients: a pilot study Prof Mok Vincent C.T
2016.065 Identifying Fluctuators in Parkinson's Disease with Objective Assessment Technology Prof. MOK Vincent C.T.
莫仲棠
2015.449 mPower - Mobile Parkinson’s Disease Study Dr. MOK Vincent C.T.
莫仲棠
2015.574 Establishment of reference genome of Hong Kong population for biomarker identification in Alzheimer's disease Prof. MOK Vincent C.T.
莫仲棠
2016.666 A Review Of Myotonic Dystrophy In Hong Kong Prof. MOK Vincent Chung Tong
莫仲棠
2017.621 A novel imaging marker facilitates early identification of small vessel disease Prof. MOK Vincent Chung Tong
莫仲棠
2014.362 A retrospective cross-sectional study of different types of Traditional Chinese Medicine for post-stroke rehabilitation in Hong Kong Prof. MOK Vincent Chung Tong
2016.404 Hepcidin as Diagnostic Marker for PD and Other Neurodegenerative Diseases Prof. MOK Vincent Chung Tong
莫仲棠
2016.099 Enhanced External Counterpulsation for Cerebral Confluent White Matter Hyperintensities Prof. MOK Vincent Chung Tong
莫仲棠
2015.682 A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE Prof. MOK Vincent Chung Tong
莫仲棠
2014.227 A multicenter, double-blind, placebo-controlled, randomised, paralle-group phase 3 study to evaluate the safety and efficacy of masitinib in patients with mild to moderate Alzheimer’s disease Prof. MOK Vincent Chung Tong
2017.254 Identifying biomarkers in Alzheimer’s disease Prof. MOK Vincent Chung Tong
莫仲棠
2016.318 Cerebral white matter hyperintensities, connectivity disruption and cortical thinning in elderly with small vessel disease Prof. MOK Vincent Chung Tong
莫仲棠
2017.337 Impact of oculomotor deficits on dynamic visual functions in Parkinson's Disease Prof. MOK Vincent Chung Tong
莫仲棠
2017.109 Plasma microRNA dysregulation for the identification of smal vessel disease Prof. MOK Vincent Chung Tong
莫仲棠
2014.360 Burden, distress and quality of life and moderating effects of mental flexibility and personality traits in caregivers of patients with Frontotemporal Lobar Degeneration Prof. MOK Vincent Chung Tong
2016.176 A prospective cohort study: The use of iPhone ECG monitoring in acute ischemic stroke during hospitalization in Hong Kong Prof. MOK Vincent Chung Tong
莫仲棠
2017.576 An alternative method to identify cerebral small vessel disease using retinal vascular imaging Prof. MOK Vincent Chung Tong
莫仲棠
2009.495 Early Identificaion of significant subclinical brain lesions in community-dwelling elderly persons in Hong Kong Prof Mok Vincent Chung Tong
2011.406 Adaptation of the Booklet Category Test in Chinese: A pilot study Prof MOK Vincent Chung Tong
2013.433 Development of normative data for NINDS - Canadian Stroke Network Vascular Cognitive Impairment Neuropsychology Protocols Prof. MOK Vincent Chung Tong
2011.238 Comparative assessment of difference in reward processing of the brain among normal subjects, stroke patients and major depressive disorder patients Prof. MOK Vincent Chung Tong
2011.090 Risk index for screening subclinical brian lesions in communitydwelling elderly persons in Hong Kong Prof. MOK Vincent Chung Tong
2010.540 Transcranial Doppler Ultrasound for Detection of Cerebral White Matter Changes in High-Risk Population Prof Mok Vincent Chung Tong
2009.032 Neuroimaging Predictors for Cognitive Impairment in Chinese Patients with Confluent White Matter Lesion Prof Mok Vincent Chung Tong
2009.530 Efficacy of Rivastigmine Transdermal Patch in Dementia Patients who do not benefit from Oral Acetylcholinesterase Inhibitors (AChIs) Prof Mok Vincent Chung Tong
2013.025 Cilostazol and Cerebral Haemodynamics in Cerebral Small Vessel Disease Prof. Mok Vincent Chung Tong
2014.023 Hong Kong Registry of Early Onset Dementia Prof. MOK Vincent Chung Tong
2008.240 A Pilot Study Using Pittsburg Compound-B Positron Emission Tomography in the Evalulation of Poststroke Dementia Prof Mok Vincent Chung Tong
2020.194 Effectiveness of oculomotor training on dynamic vision and functional performance in Parkinson’s disease – A randomized clinical trial Prof. MOK Vincent Chung Tong
莫仲棠
2020.620 A Phase 3, multi-center, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy and safety of sodium oligomannate (GV-971) in treatment of mild to moderate Alzheimer’s disease (GREEN MEMORY: GREen Valley 971 EvaluatioN Memory) Prof. MOK Vincent Chung Tong
莫仲棠
2018.334 A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION OF PHASE III STUDIES (BN29552/BN29553) OF CRENEZUMAB IN PATIENTS WITH ALZHEIMER’S DISEASE Prof. MOK Vincent Chung Tong
莫仲棠
2018.615 Follow-up study of a cuffless blood pressure monitoring device for dementia evaluation (Phase II) Prof. MOK Vincent Chung Tong
莫仲棠
2019.391 Transcranial Pulse Stimulation (TPS) for Neurological diseases Pilot study Prof. MOK Vincent Chung Tong
莫仲棠
2019.350 Comprehensive Analysis Of Molecular, Structural And Functional Biomarkers For Alzheimer's Disease In The Chinese Population (UAD) Prof. MOK Vincent Chung Tong
莫仲棠
2020.374 Longitudinal follow up study of patients with Alzheimer’s disease using advanced multiparametric MR imaging Prof. MOK Vincent Chung Tong
莫仲棠

Page 172 of 262.